Päivi Lähteenmäki profile picture
Päivi
Lähteenmäki
Docent, Department of Clinical Medicine
Paediatrics and Adolescent Medicine
MD, PhD Docent (Adjunct professor); Medicine (Department of Clinical Medicine)

Contact

Links

CURRICULUM VITAE2019_utu.pdf
ORCID

Areas of expertise

Pediatric and adolescent hematology and oncology
Late-effects of cancer treatment at an early age
Quality improvement and registration.

Biography

Päivi Lähteenmäki graduated from the Medical School at the University of Turku in 1984, where she also specialized in Pediatrics and PediatricHematology and Oncology. She defended her thesis in 1999 on Effects of childhood cancer on patients and their families - physical and psychosocial aspects. She worked in 2002 as a post-doc Clinical and Research Fellow at Bristol Sick Children’s Hospital BMT Unit, Bristol, UK. Subsequently, she has worked as a Consultant at the Department of Pediatrics, University of Turku. Since 2008, she has been Docent (Adjunct Professor) of Pediatric Hematology and Oncology at the Faculty of Medicine, University of Turku, and Head of the Division of Pediatric and Adolescent Hematology/Oncology at Turku University Hospital in Turku, Finland. Currently she works also as the Chief of the Swedish Childhood Cancer Registry at Karolinska Institutet in Stockholm, Sweden.

During the years, Päivi Lähteenmäki has served as the chairman or a board member of the Nordic Society of Pediatric Hematology and Oncology as well as the Finnish Association of Pediatric Hematology and Oncology. In 2012-2014, She was the chair of a group planning the establishment of childhood cancer late-effect clinics in Finland. In 2016, she was awarded the Finnish Cancer Association Price, Oncologist of the year in Finland.

Teaching

Since 2008, clinical pediatric hematology and oncology at the Department of Pediatrics and Adolescent Medicine, University of Turku.

Research

Päivi Lähteenmäki´s major research interest lies in the late-effects of childhood cancer. In year 2000, she founded her own research group and initiated a long-term research project called “Health and Quality of Life in Patients with Early Age Onset Cancer” including the epidemiology, diagnosis, prevention, and overall societal impact of the late sequelae of cancer and its treatments. Päivi Lähteenmäki has been actively involved in international research collaboration. In 2006, she started a collaboration with NIH funded GCCT (Genetic consequences of cancer therapies) consortium, followed by a Nordic project ALiCCS (Adult life in childhood cancer survivors), and an EU funded project PanCareSurFup (PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies). In 2018, two new Nordic collaborations started (PACCS Physical activity in childhood cancer survivors; PACS Pregnancy associated cancer). She is also a principal investigator in NOPHO-CARE (A Nordic study on epidemiology, biology, treatment and survival of children with cancer and severe hematological diseases).

Publications

Sort by:

LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients (2023)

Neuro-Oncology
Hardin Emily C, Schmid Simone, Sommerkamp Alexander, Bodden Carina, Heipertz Anna-Elisa, Sievers Philipp, Wittmann Andrea, Milde Till, Pfister Stefan M, von Deimling Andreas, Horn Svea, Herz Nina A, Simon Michèle, Perera Ashwyn A, Azizi Amedeo, Cruz Ofelia,Curry Sarah, Van Damme An,Garami Miklos, Hargrave Darren,Kattamis Antonis,Kotnik Barbara Faganel, Lähteenmäki Päivi, Scheinemann Katrin, Schouten-van Meeteren Antoinette Y N, Sehested Astrid, Viscardi Elisabetta, Wormdal Ole Mikal, Zapotocky Michal, Ziegler David S,Koch Arend, Hernáiz Driever Pablo, Witt Olaf,Capper David, Sahm Felix, Jones David T W, van Tilburg Cornelis M
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A joint international consensus statement for measuring quality of survival for patients with childhood cancer (2023)

Nature Medicine
van Kalsbeek Rebecca J., Hudson Melissa M., Mulder Renée L., Ehrhardt Matthew, Green Daniel M., Mulrooney Daniel A., Hakkert Jessica, den Hartogh Jaap, Nijenhuis Anouk, van Santen Hanneke M., Schouten-van Meeteren Antoinette Y. N., van Tinteren Harm, Verbruggen Lisanne C., Conklin Heather M., Jacola Lisa M., Webster Rachel Tillery, Partanen Marita, Kollen Wouter J. W., Grootenhuis Martha A., Pieters Rob, Kremer Leontien C. M.; International Childhood Cancer Outcome Project participants
(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Temporal changes in incidence of relapse and outcome after relapse of childhood acute lymphoblastic leukemia over three decades; a Nordic population-based cohort study (2022)

Leukemia
Jensen Karen Schow, Oskarsson Trausti, Lähteenmäki Päivi M, Flaegstad Trond, Jónsson Ólafur Gísli, Svenberg Petter, Schmiegelow Kjeld, Heyman Mats, Norén-Nyström Ulrika, Schrøder Henrik, Albertsen Birgitte Klug
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Doing less, accomplishing more for childhood ALL: response (2022)

British Journal of Haematology
Jensen Karen, Oskarsson Trausti, Lähteenmäki Päivi, Flaegstad Trond, Schmiegelow Kjeld, Vedsted Peter, Albertsen Birgette, Schroder Henrik
(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))
People search